This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Mon, 03/17/2025 - 14:56 March 17, 2025 Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Associations flagship journal Circulation. are forms of congenital heart defects (CHD). In the U.S.,
A cancer therapy that prompts the body's immune defenses against viruses and bacteria to attack tumors can make patients more vulnerable to heart attack and stroke. A possible explanation for this side effect is that the treatment interferes with immune regulation in the heart's largest blood vessels, a new study suggests.
Bayer terminated its OCEANIC-AF trial for its Factor XI inhibitor, asundexian, due to 3x greater stroke (1.3% vs. 0.4%) and 4x higher ischemic stroke rates (csHR = 4.06). Results from BMS AXIOMATIC-SSP study found that its Factor XI inhibitor, milvexian, failed to meaningfully reduce ischemic stroke.
Methods The study was based on the Danish Diet, Cancer and Health cohort. We assessed the risk of heart failure (HF), ischaemic stroke (IS) and all-cause mortality during 10 years of follow-up in participants with both AF and AMI compared with only one and according to the temporal order of AF and AMI in participants with both conditions.
Radon is the second leading cause of lung cancer. Now a new study has found exposure to this invisible, odorless gas is also linked to an increased risk of stroke. The study does not prove that exposure to radon causes stroke; it only shows an association.
A cancer therapy that prompts the body's immune defenses against viruses and bacteria to attack tumors can make patients more vulnerable to heart attack and stroke. A possible explanation for this side effect is that the treatment interferes with immune regulation in the heart's largest blood vessels, a new study suggests.
A study based on clinical trial data found higher risks of stroke, heart attack, and hospital admission for heart failure in older cancer survivors. In the analysis published in the journal Cancer, chemotherapy was also linked to elevated rates of these conditions.
(MedPage Today) -- Through my work as a neuroscientist who designs neural implants to monitor the injured brain after severe traumatic brain injuries, stroke, and brain cancers, it has become very clear to me that my field needs to communicate.
Among adults ages 18-49 (median age of 41 years) who were born with a hole in the upper chambers of their heart known as patent foramen ovale (PFO), strokes of unknown cause were more strongly associated with nontraditional risk factors, such as migraines, liver disease or cancer, rather than more typical factors such as high blood pressure.
Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the disease.
Stroke, Volume 56, Issue Suppl_1 , Page ATP295-ATP295, February 1, 2025. Background:It is suggested that survivors of different types of cancer may have an increased risk of stroke. Our study aims to evaluate cancer patients and non-cancer controls by analyzing stroke events in each group. Review Manager 5.4
Stroke, Volume 56, Issue Suppl_1 , Page AWP109-AWP109, February 1, 2025. Introduction:Comorbid active cancer among in-hospital onset acute ischemic stroke (IHS) is increasing. Patients characteristics, time course, of initial management and clinical outcome were compared in both groups.
Stroke, Volume 56, Issue Suppl_1 , Page AWP272-AWP272, February 1, 2025. However, there are no existing data supporting an independent relationship between cancer and atrial cardiopathy, another atrial pathology associated with increased acute ischemic stroke (AIS) risk. The study exposure was active cancer.
Müller milla1cf Wed, 05/01/2024 - 12:07 May 1, 2024 — In an ischemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Dr Nils Lehnen, Senior Physician at the Clinic for Diagnostic and Interventional Neuroradiology and Paediatric Neuroradiology at the UKB.
Stroke, Volume 56, Issue Suppl_1 , Page ATP306-ATP306, February 1, 2025. Background:Cancer is a leading cause of mortality and a well-known risk factor for ischemic stroke. However, the relationship between cancer and stroke is not well studied. The prevalence of shunt is assessed using 95% confidence intervals (CI).Results:Among
Stroke, Volume 56, Issue Suppl_1 , Page AWP155-AWP155, February 1, 2025. Background:Cancer-related stroke (CRS) is a rare condition where a tumor or its metastasis can compress a blood vessel and result in stroke. Patients were divided into those with strokes (ischemic or hemorrhagic) and those without strokes.
Cancer patients have a higher risk of atrial fibrillation (AF) than general population, however, the link between cancer and AF is not fully understood. The association between AF detected by implanted cardiac implantable electronic devices (CIEDs) and the incidence of embolic stroke has been reported.
Stroke, Volume 55, Issue Suppl_1 , Page ATP230-ATP230, February 1, 2024. Introduction:Atrial fibrillation (AF) and cancer are both independently associated with worse outcomes in patients with acute ischemic stroke. Few studies have evaluated the impact of AF on outcomes of cancer-related stroke.
Stroke, Volume 55, Issue Suppl_1 , Page AWP237-AWP237, February 1, 2024. population with active cancer. population with active cancer. had active cancer. had active cancer. female; common cancer types: 25.3% ischemic stroke). gastrointestinal, 20.3% prostate, 18.4% per 100 person-years (66.7%
In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a new study.
Background:Cancer and obstructive sleep apnea (OSA) individually elevate cardiovascular diseases (CVD) and stroke risk. Patients were eligible to enter the cohort on the day of cancer diagnosis. Among persons with cancer, OSA diagnosis was associated with increased risk of adverse CVD outcomes (HR: 1.37, 95% CI: 1.36 – 1.38).
Stroke, Volume 56, Issue Suppl_1 , Page ATP285-ATP285, February 1, 2025. Introduction:Previous studies have observed an increased risk of stroke in head and neck cancer (HNC) survivors. Conclusion:We report an increased risk of stroke in HNC patients, which is consistently raised when compared with the general population.
Stroke, Volume 56, Issue Suppl_1 , Page AWP318-AWP318, February 1, 2025. Background:Approximately 50% of ischemic strokes in patients with cancer are classified as cryptogenic after standard evaluation. History of cancer was associated with higher median values of NT-proBNP (126 versus 103 pg/mL, p<0.001) and LADI (1.9
Stroke, Volume 56, Issue Suppl_1 , Page ATP311-ATP311, February 1, 2025. Introduction:Immune Checkpoint Inhibitors (ICIs) used for treatment of malignancies might promote atherosclerosis and increase the risk of ischemic stroke (IS). We collected demographics and stroke characteristics. range 27-386) vs. ICI 337.5
The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.
The majority require explant of the TAVR device and SAVR, which significantly increases the risk of operative mortality and stroke. Operative mortality and stroke were elevated in SAVR after TAVR patients with or without concomitant CABG at 9.3% and 3.8%, respectively.
Oncology Oncology fellowships delve into cancer care, focusing on advancements in chemotherapy, immunotherapy, and targeted treatments. These programs prepare physicians to lead in the fight against cancer, both in clinical and research settings. Here’s how it can influence your professional journey: 1.
Limited data indicate an elevated risk of atrial fibrillation (AF) after neoadjuvant chemoradiation in esophageal cancer however the role of AF as an independent predictor of outcomes post-esophagectomy remains under-studied. Outcomes over a 5-year period were mortality, ischemic stroke, and use of anticoagulation.
Stroke, Ahead of Print. BACKGROUND:Ischemic stroke is often accompanied by oxidative stress and inflammatory response, both of which work synergistically to exacerbate the disruption of the blood-brain barrier and ischemic brain injury. The ALK inhibitor alectinib was administered following the stroke.
These results suggest that abelacimab may be safe across the spectrum of bleeding risk and may make it possible to anticoagulate some of the most vulnerable populations who otherwise would not be treated and therefore left unprotected from the risk of stroke. Data from these trials are expected in the second half of 2026.
Stroke, Volume 55, Issue Suppl_1 , Page ATP120-ATP120, February 1, 2024. Background:Racial disparities in stroke prevalence and outcomes have been well documented in previous studies, but there is not sufficient data based on post-menopausal women. 95%, p- 0.017), cancer (OR: 1.27 95%, p- 0.017), cancer (OR: 1.27
This is particularly relevant in the cancer patient population, where pulmonary embolism is a significant cause of mortality. Unsuspected pulmonary embolism is a common finding in routine CT scans of the chest, but as little as 25% of emboli are reported during the initial interpretation.
Many of the drugs that have been developed have been studied in clinical trials evaluating their use in secondary prevention of acute coronary syndromes, prevention of venous thromboembolism after orthopedic surgery, and stroke and systemic embolism prevention.
Stroke, Volume 55, Issue Suppl_1 , Page ATP233-ATP233, February 1, 2024. Introduction:Breast cancer susceptibility gene (BRCA) mutations are well-known causes of systemic cancers. Our comparative cohort were individuals with breast cancer who have a genetically confirmed BRCA wildtype status.
panel additionally plans to retreat from its 2016 advice to take toddler aspirin for the prevention of colorectal cancer, steering that become groundbreaking on the time. The panel stated greater current statistics had raised questions on the blessings of cancer, and that greater studies become needed.
Stroke, Volume 55, Issue Suppl_1 , Page ATP316-ATP316, February 1, 2024. Introduction:Tamoxifen (TAM), a selective estrogen receptor modulator, is a first-line treatment to prevent recurrence of hormone receptor positive breast cancer. Critically, women taking TAM as breast cancer therapy had increased risk of ischemic stroke (82%).
Stroke, Volume 56, Issue Suppl_1 , Page ATP229-ATP229, February 1, 2025. Frequently, carotid artery stenosis is found during stroke workup and these patients undergo revascularization during the same nonelective admission.
Identify accumulated blood clots that can result in heart diseases, cancer, or emphysema. Also, the technology helps in stroke detection by enabling the software to find large vessel occlusions that can further cause a stroke. The reports are immediately sent to the stroke team so that appropriate action can be taken in time.
Stroke, Volume 55, Issue Suppl_1 , Page AWP302-AWP302, February 1, 2024. Background and Objectives:Understanding the mechanisms of thrombosis is crucial for the future advancement in treating ischemic stroke. Clot volume was semiautomatically measured on thin-section computed tomography performed at stroke presentation using software.
1 People suffering from PAD have not only impaired quality of life but also increased risk of heart attack or stroke. PAD affects more than eight million people aged 40 and older in the United States. 2 CLTI is the most advanced and serious form of PAD, impacting nearly 2 million patients in the U.S.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2024. Cancer-related CVT was associated with a higher rate of readmission (p<0.0001) and traumatic CVT was associated with a lower rate (p=0.005). years (SD 19). Median time-to-first readmission is 1.8 years (95% CI 1.4-2.4),
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionInternuclear ophthalmoplegia (INO) is an ocular movement disorder typically due to a lesion in the medial longitudinal fasciculus (MLF). Rarely, similar ocular movement abnormalities can be observed in the absence of an MLF lesion.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content